Can Fite Biopharma Ltd - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Can Fite Biopharma Ltd - ADR
Can Fite Biofarma Ltd is an clinical-stage biopharmaceutical company. The company develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The company's platform technology utilizes the Gi protein associated A3 adenosine receptor, or A3AR, as a therapeutic target. The company's drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).
/ 
Frequently asked questions
To buy Can Fite Biopharma Ltd - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Can Fite Biopharma Ltd - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Can Fite Biopharma Ltd - ADR is CANF:xase. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Can Fite Biopharma Ltd - ADR has its primary listing on NYSE American. You can trade Can Fite Biopharma Ltd - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Can Fite Biopharma Ltd - ADR is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Can Fite Biopharma Ltd - ADR as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Can Fite Biopharma Ltd - ADR.